| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 50,857 | 69,532 | 72,786 | 74,412 | | Cost of Revenue | 17,954 | 21,856 | 22,509 | 25,685 | | | Gross Profit | 32,903 | 47,676 | 50,277 | 48,727 | | | Operating Expenses | | Research Development | 9,052 | 12,881 | 13,595 | 13,179 | | Selling General and Administrative | 20,412 | 25,718 | 26,340 | 27,229 | | Non Recurring | 45 | 2 | 45 | 664 | | Others | 427 | 444 | 444 | 445 | | | | Total Operating Expenses | 29,936 | 39,045 | 40,424 | 41,517 | | | | Operating Income or Loss | 2,967 | 8,631 | 9,853 | 7,210 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 1,824 |
-
| 88 | | Earnings Before Interest And Taxes | 2,728 | 10,455 | 9,853 | 7,298 | | Interest Expense |
-
| (377) | 377 | 584 | | Income Before Tax | 2,728 | 10,832 | 9,476 | 6,714 | | Income Tax Expense | 555 | 2,810 | 3,247 | 521 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,173 | 8,022 | 6,229 | 6,193 | | | Non-recurring Events | | Discontinued Operations | 2,499 |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 4,672 | 8,022 | 6,229 | 6,193 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $4,672 | $8,022 | $6,229 | $6,193 |
|
0.51% Nasdaq 
Income Statement
